Epidemiological study using IgM and IgG antibody titers against SARS-CoV-2 in The University of Tokyo, Japan (UT-CATS).

导出 OA

翻译打印收藏纠错

作者： Akihisa,Mitani ^[1] ; Kensuke,Hamada ^[2] ; Naoyuki,Yoshikawa ^[3] ; Yoshifumi,Morita ^[3] ; Takeshi,Horie ^[2] ; Yukiko,Inoue ^[2] ; Minako,Saito ^[2] ; Takashi,Ishii ^[2] ; Mitsuhiro,Sunohara ^[2] ; Ryota,Takahashi ^[2] ; Noriko,Emoto ^[2] ; Nahoko,Nishimoto ^[2] ; Yoko,Murano ^[2] ; Sachiko,Okazaki ^[2] ; Shoko,Tateishi ^[2] ; Atsushi,Yao ^[2] ; Takuya,Shimura ^[3] ; Makoto,Kurano ^[3] ; Yutaka,Yatomi ^[3] ; Shintaro,Yanagimoto ^[2]

作者单位： Division for Health Service Promotion, The University of Tokyo, Japan. Electronic address: mitania-tky@umin.ac.jp. ^[1] Division for Health Service Promotion, The University of Tokyo, Japan. ^[2] Department of Clinical Laboratory, The University of Tokyo Hospital, Japan. ^[3]

关键词 Antibody titers Chemiluminescent immunoassay (CLIA)IgG IgM Seroepidemiological study Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

主题词抗体, 病毒(Antibodies, Viral);流行病学研究(Epidemiologic Studies);人类(Humans);免疫球蛋白G(Immunoglobulin G);免疫球蛋白M(Immunoglobulin M);日本(Japan)

DOI 10.1016/j.jiac.2021.06.008

PMID 34158239

发布时间 2021-08-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交